These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 7817458

  • 21. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 22. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
    Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H.
    Prog Clin Biol Res; 1990 Apr; 353():219-24. PubMed ID: 2217422
    [No Abstract] [Full Text] [Related]

  • 23. [Clinical analysis of bladder cancer patients treated by radical cystectomy].
    Kageyama S, Yoshiki T, Hamaguchi A, Konishi T, Okada Y, Park KI, Tomoyoshi T.
    Hinyokika Kiyo; 1997 Jan; 43(1):1-6. PubMed ID: 9046413
    [Abstract] [Full Text] [Related]

  • 24. [Adjuvant chemotherapy after radical cystectomy in bladder carcinoma].
    Dunst J.
    Strahlenther Onkol; 1995 Nov; 171(11):662-3. PubMed ID: 7502232
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.
    Leissner J, Koeppen C, Wolf HK.
    J Urol; 2003 Mar; 169(3):955-60. PubMed ID: 12576821
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 30. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
    Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF.
    J Urol; 2002 Mar; 167(3):1295-8. PubMed ID: 11832716
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [Abstract] [Full Text] [Related]

  • 33. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Ferreira U, Matheus WE, Nardi Pedro R, Levi D'Ancona CA, Reis LO, Stopiglia RM, Denardi F, Rodrigues Netto N, de Cássio Zequi S, da Fonseca FP, Lopes A, Cardoso Guimarães G, de Carvalho Fernandes R, Cardenuto Perez MD.
    Urol Int; 2007 Apr; 79(3):200-3. PubMed ID: 17940350
    [Abstract] [Full Text] [Related]

  • 34. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer.
    Stein JP, Skinner DG.
    BJU Int; 2003 Jul; 92(1):12-7. PubMed ID: 12823375
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 40. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S.
    Scand J Urol Nephrol; 2002 Sep 20; 36(5):339-43. PubMed ID: 12487737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.